drugset
drugset / Trial / NCT04333290

Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent

NCT04333290 ↗

Phase 0 Withdrawn Robert Fox Case Western Reserve University · collab
NaSingle-groupOpen-labelDiagnostic

Summary

This study evaluates the safety of \[11C\]MeDAS, a PET radiotracer.

Timeline

Start
2024-07-24
Primary completion
2024-07-25
Completion
2024-07-25

Outcome

Outcome not reported

Stopped: “Unable to obtain Myeliviz for trial”

Drugs

EvaluationDrugModalityDoseRoute
Subject [11C]MeDAS Diagnostic / imaging agent — —

Indications

No indication recorded.